SATB2 by Immunohistochemistry
Also known as: SATB2 IHC
Use
SATB2 by immunohistochemistry is used in pathology to detect the presence of special AT-rich sequence-binding protein 2 (SATB2) in tissue samples. SATB2 is a protein associated with certain types of cancer and other medical conditions. The test helps in the differential diagnosis and characterization of tumors, particularly in distinguishing colorectal carcinomas and certain sarcomas from other neoplasms. Its expression profile can provide valuable information for pathologists in the diagnostic process.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. This test is a stain and return (technical) service only, meaning it provides a technical service without interpretation. It is intended for clinical purposes, conducted in a CLIA-certified laboratory.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
SATB2
Protein
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
2 slides
Container
Tissue Transport Kit
Collection Instructions
Formalin fix (10 percent neutral buffered formalin) and paraffin embed specimen (cells must be prepared into a cellblock). Transport tissue block or 5 unstained (3- to 5-micron thick sections), positively charged slides.
Storage Instructions
Room temperature. Ship in cooled container during summer months.
Causes for Rejection
Specimens submitted with nonrepresentative tissue type. Depleted specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant